It is specifically interesting to note (given our identification of ORAI3 regulation of both migratory and immune/inflammatory pathways by hypoxia) that PGF is believed to reprogram the tumor immune microenvironment and contribute to obesity-promoted breast cancer progression [64]. The gene discussed is ORAI3; the disease is obesity due to melanocortin 4 receptor deficiency.